In the study by Li et al., curcumin-loaded lipid-polymer-lecithin hybrid nanoparticles (CUR-NPs) were synthesized and functionalized with RNA Aptamers (Apts) against EpCAM for targeted delivery to CRC cells [112]. This evidence concerns the gene EPCAM and colorectal carcinoma.